Douglass Winthrop Advisors, LLC Amgen Inc Transaction History

Douglass Winthrop Advisors, LLC

$4.96 Billion
Q4 2024

A detailed history of Douglass Winthrop Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 14,140 shares of AMGN stock, worth $4.44 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

14,140

Previous 14,240 0.7%

Holding current value

$4.44 Million

Previous $4.59 Million 19.68%

% of portfolio

0.07%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$258.78 - $328.31 $25,877 - $32,831	-100 Reduced 0.7%	14,140 $3.69 Million
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $3,093 - $3,373	-10 Reduced 0.07%	14,240 $4.59 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $26,275 - $31,931	-100 Reduced 0.7%	14,250 $4.45 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $52,429 - $63,289	195 Added 1.38%	14,350 $4.08 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $125,723 - $156,089	-575 Reduced 3.9%	14,155 $3.8 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $14,570 - $17,229	68 Added 0.46%	14,730 $3.27 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $35,900 - $43,756	-159 Reduced 1.07%	14,662 $3.55 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $45,806 - $58,202	-200 Reduced 1.33%	14,821 $3.89 Million
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $130,635 - $147,333	-582 Reduced 3.73%	15,021 $3.39 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $26,300 - $29,268	114 Added 0.74%	15,603 $3.8 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1.22 Million - $1.35 Million	-5,575 Reduced 26.47%	15,489 $3.75 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $1.42 Million - $1.62 Million	-7,120 Reduced 25.26%	21,064 $4.74 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $37,784 - $44,268	-178 Reduced 0.63%	28,184 $5.99 Million
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $63,533 - $70,486	-272 Reduced 0.95%	28,362 $6.91 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $521,488 - $607,710	-2,350 Reduced 7.58%	28,634 $7.12 Million
Q4 2020 Jan 27, 2021	BUY	$216.38 - $257.67 $12,766 - $15,202	59 Added 0.19%	30,984 $7.12 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $18.4 Million - $20.5 Million	-78,400 Reduced 71.71%	30,925 $7.86 Million
Q2 2020 Jul 17, 2020	SELL	$197.81 - $242.74 $1.95 Million - $2.39 Million	-9,855 Reduced 8.27%	109,325 $25.8 Million
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $37.1 Million - $49.2 Million	-203,521 Reduced 63.07%	119,180 $24.2 Million
Q4 2019 Jan 10, 2020	BUY	$189.21 - $243.2 $519,381 - $667,584	2,745 Added 0.86%	322,701 $77.8 Million
Q3 2019 Oct 08, 2019	BUY	$174.11 - $208.62 $3.07 Million - $3.68 Million	17,651 Added 5.84%	319,956 $61.9 Million
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $2.28 Million - $2.67 Million	13,685 Added 4.74%	302,305 $55.7 Million
Q1 2019 Apr 09, 2019	BUY	$180.87 - $203.88 $819,341 - $923,576	4,530 Added 1.59%	288,620 $54.8 Million
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $2.98 Million - $3.47 Million	16,685 Added 6.24%	284,090 $55.3 Million
Q3 2018 Oct 12, 2018	BUY	$185.29 - $208.89 $683,349 - $770,386	3,688 Added 1.4%	267,405 $55.4 Million
Q2 2018 Jul 24, 2018	SELL	$166.05 - $186.51 $327,782 - $368,170	-1,974 Reduced 0.74%	263,717 $48.7 Million
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $5.94 Million - $6.94 Million	35,053 Added 15.2%	265,691 $45.3 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $622,497 - $695,519	3,688 Added 1.63%	230,638 $40.1 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $38 Million - $43.3 Million	226,950	226,950 $0

Others Institutions Holding AMGN

# of Institutions

3,180

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $168B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Account

Douglass Winthrop Advisors, LLC Amgen Inc Transaction History